Dario Ferrero

CEP-18770: A novel, orally active proteasome inhibitor with a tumor-selective pharmacologic profile competitive with bortezomib

Roberto Piva, Bruce Ruggeri, Michael Williams et al. · Blood · 2007 · 253 citations · Full text

Medicine, Oncology, Pharmacology +9

Ras oncogene mutation in multiple myeloma.

Antonino Neri, James P. Murphy, Dario Ferrero et al. · The Journal of Experimental Medicine · 1989 · 171 citations · Full text

Medicine, Genetics, Oncology +17

Significant Correlation Between the Degree of WT1 Expression and the International Prognostic Scoring System Score in Patients With Myelodysplastic Syndromes

Daniela Cilloni, Enrico Gottardi, Francesca Messa et al. · Journal of Clinical Oncology · 2003 · 154 citations

Life Sciences, Hematology, Molecular Biology +17

Azacitidine for the treatment of patients with acute myeloid leukemia

Luca Maurillo, Adriano Venditti, Alessandra Spagnoli et al. · Cancer · 2011 · 144 citations

Medicine, Pharmacology, Pharmacotherapy +17

Induction of differentiation of HL-60 cells by dimethyl sulfoxide: evidence for a stochastic model not linked to the cell division cycle.

Corrado Tarella, Dario Ferrero, Eugenio Gallo et al. · PubMed · 1982 · 138 citations

Life Sciences, Cancer Biology, Cell Biology +13